Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Antonella Turla
Observed names:
A. Turla,
ANTONELLA TURLA,
Turla Antonella,
Turla, Antonella
Institutions:
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia,
Aziende Socio Sanitarie Territoriale della Valcamonica,
University of Brescia
Observed institutions:
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia,
Aziende Socio Sanitarie Territoriale della Valcamonica,
University of Brescia
ORCID:
0000-0002-8018-588X
Observed ORCID:
0000-0002-8018-588X
OpenAlex ID:
A5019195599
Changes in eating habits and food preferences in breast cancer patients undergoing adjuvant chemotherapy
2021
·
Rebecca Pedersini
, Pierluigi di Mauro
, et al.
·
Scientific Reports
·
50
PDF
Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy
2019
·
Rebecca Pedersini
, Vito Amoroso
, et al.
·
JAMA Network Open
·
45
PDF
Treatment and outcome of metastatic parathyroid carcinoma: A systematic review and pooled analysis of published cases
2022
·
Andrea Alberti
, Davide Smussi
, et al.
·
Frontiers in Oncology
·
40
The Interaction of Lean Body Mass With Fat Body Mass Is Associated With Vertebral Fracture Prevalence in Women With Early Breast Cancer Undergoing Aromatase Inhibitor Therapy
2020
·
Sara Monteverdi
, Rebecca Pedersini
, et al.
·
JBMR Plus
·
31
Ovarian Strumal Carcinoid: Case Report, Systematic Literature Review and Pooled Analysis
2022
·
Antonella Turla
, Manuel Zamparini
, et al.
·
Frontiers in Endocrinology
·
28
PDF
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma
2022
·
M. Laganà
, S. Grisanti
, et al.
·
ESMO Open
·
26
PDF
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art?
2022
·
Valentina Cremaschi
, Andrea Abate
, et al.
·
Expert Opinion on Pharmacotherapy
·
25
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen
2022
·
Antonella Turla
, Marta Laganà
, et al.
·
Endocrine
·
21
PDF
Taste alterations during neo/adjuvant chemotherapy and subsequent follow-up in breast cancer patients: a prospective single-center clinical study
2022
·
Rebecca Pedersini
, Manuel Zamparini
, et al.
·
Supportive Care in Cancer
·
17
Efficacy of the DigniCap System in preventing chemotherapy‐induced alopecia in breast cancer patients is not related to patient characteristics or side effects of the device
2020
·
Rebecca Pedersini
, Carla Fornaro
, et al.
·
International Journal of Nursing Practice
·
14
Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines?
2021
·
Salvatore Grisanti
, Deborah Cosentini
, et al.
·
Endocrine
·
12
PDF
Extended Adjuvant Endocrine Treatment in Luminal Breast Cancers in the Era of Genomic Tests
2022
·
Mariarosaria Saponaro
, Luigi Annunziata
, et al.
·
International Journal of Molecular Sciences
·
9
PDF
Taste Alterations Do Not Affect Change in Food Habits and Body Weight in Breast Cancer Patients
2022
·
REBECCA PEDERSINI
, PIERLUIGI DI MAURO
, et al.
·
In Vivo
·
9
PDF
Efficacy of Eribulin mesylate in older patients with breast cancer: A pooled analysis of clinical trial and real-world data
2020
·
Rebecca Pedersini
, Pierluigi di Mauro
, et al.
·
Journal of Geriatric Oncology
·
8
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma
2021
·
Deborah Cosentini
, Antonella Turla
, et al.
·
Frontiers in Endocrinology
·
7
PDF
Emerging Treatment Options for Neuroendocrine Neoplasms of Unknown Primary Origin: Current Evidence and Future Perspectives
2024
·
Francesca Corti
, Roberta Elisa Rossi
, et al.
·
Cancers
·
6
PDF
Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status
2023
·
Antonella Turla
, Marta Laganà
, et al.
·
Cancers
·
5
PDF
Letter to the Editor From Cosentini et al: “Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients’ Survival”
2022
·
Deborah Cosentini
, Marta Laganà
, et al.
·
The Journal of Clinical Endocrinology & Metabolism
·
4
PDF
Outcome of brain metastases from adrenocortical carcinoma: a pooled analysis
2023
·
A. Turla
, M. Laganà
, et al.
·
Journal of Endocrinological Investigation
·
3
PDF
Adiposity Excess and Vertebral Fractures in Patients With Breast Cancer Taking Aromatase Inhibitors
2026
·
Greta Schivardi
, Deborah Cosentini
, et al.
·
JAMA Network Open
·
1
Efficacy of RET inhibitors in the management of advanced, RET mutated, pheochromocytoma. Pooled analysis of published cases with the addition of 2 new cases
2026
·
Valentina Cremaschi
, Marta Laganà
, et al.
·
Endocrine
·
1
417P New insights into second-line (2L) choices after CDK4/6 inhibitors (CDK4/6i) in hormone receptor-positive (HR+)/ human epidermal growth factor 2-negative (HER2-) metastatic breast cancer (MBC) patients (pts): Preliminary results of the HERMIONE-13 study
2023
·
V. Cogliati
, E. Rossi
, et al.
·
Annals of Oncology
·
1
PDF
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic
2021
·
Cristina Gurizzan
, Rebecca Pedersini
, et al.
·
Frontiers in Oncology
·
1
PDF
Use of Metronomic Chemotherapy in Hormone Receptor‐Positive/ HER2 ‐Negative Metastatic Breast Cancer: A Retrospective Multicenter Study
2026
·
Lara Laini
, Deborah Cosentini
, et al.
·
Cancer Medicine
PDF
Antineoplastic effect of block-and-replace strategy for managing hypercortisolism caused by adrenal cortical carcinoma
2026
·
Davide Lorenzo Bettini
, Sara Rodella
, et al.
·
JCEM Case Reports
Show more works
View as search
Works count:
43
Citation count:
364
H-index:
11
I10-index:
11
Year
Topic
Type